Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610072, PR China.
School of Medical and Life Sciences/Reproductive & Women-Children Hospital, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, 610041, PR China.
Biomed Pharmacother. 2021 May;137:111303. doi: 10.1016/j.biopha.2021.111303. Epub 2021 Jan 29.
Cerebral ischemia-reperfusion injury can lead to a series of serious brain diseases and cause death or different degrees of disability. Polysaccharide is a kind of biological macromolecule with multiple pharmacological activities and has been proven that it may be used for the treatment of cerebral I/R injury in the future. By sorting out all relevant research from 2000 to 2020, we selected 74 references and identified 22 kinds of polysaccharides. Almost all of these polysaccharides are extracted from traditional Chinese medicine. Research shows that these polysaccharides can improve cerebral ischemia-reperfusion injury through anti-oxidative stress, inhibiting the neuroinflammation, glutamate neurotoxicity and neuronal apoptosis, and exerting neurotrophic effect. The specific mechanisms include clearing ROS and RNS, inhibiting the expression of inflammatory factors, maintaining mitochondrial homeostasis and blocking caspase cascade, regulating NMDA receptor and promoting angiogenesis. We hoped this review is instructive for researchers to design, research and develop polysaccharides.
脑缺血再灌注损伤可导致一系列严重的脑部疾病,并导致死亡或不同程度的残疾。多糖是一种具有多种药理活性的生物大分子,已被证明将来可能用于治疗脑 I/R 损伤。通过对 2000 年至 2020 年的所有相关研究进行梳理,我们选择了 74 篇参考文献,并确定了 22 种多糖。几乎所有这些多糖都从中药中提取。研究表明,这些多糖可以通过抗氧化应激、抑制神经炎症、谷氨酸神经毒性和神经元凋亡以及发挥神经营养作用来改善脑缺血再灌注损伤。具体机制包括清除 ROS 和 RNS、抑制炎症因子的表达、维持线粒体稳态和阻断 caspase 级联、调节 NMDA 受体和促进血管生成。我们希望这篇综述对研究人员设计、研究和开发多糖具有指导意义。